Phathom Pharmaceuticals, Inc. financial data

Symbol
PHAT on Nasdaq
Industry
Pharmaceutical Preparations
Location
100 Campus Drive,, Suite 102, Florham Park, New Jersey
State of incorporation
Delaware
Fiscal year end
December 31
Latest financial report
10-Q - Q2 2024 - Aug 8, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 828 % -6.74%
Quick Ratio 3.23 %
Debt-to-equity -381 % +30.3%
Return On Equity 251 % -40.9%
Return On Assets -89.6 % +6.05%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 59.6M shares +4.91%
Common Stock, Shares, Outstanding 58.6M shares +3.46%
Entity Public Float 526M USD +166%
Common Stock, Value, Issued 5K USD 0%
Weighted Average Number of Shares Outstanding, Basic 58.6M shares +20.7%
Weighted Average Number of Shares Outstanding, Diluted 58.6M shares +20.7%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 7.32M USD
Cost of Revenue 1.38M USD
Research and Development Expense 42.5M USD -28.3%
General and Administrative Expense 91.6M USD +2.05%
Operating Income (Loss) -253M USD -67.5%
Nonoperating Income (Expense) -44.3M USD -30.5%
Net Income (Loss) Attributable to Parent -297M USD -60.7%
Earnings Per Share, Basic -5.18 USD/shares -18.3%
Earnings Per Share, Diluted -5.18 USD/shares -18.3%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 276M USD +11%
Inventory, Net 2.18M USD +1861%
Assets, Current 305M USD +18.3%
Property, Plant and Equipment, Net 1.81M USD +56.6%
Operating Lease, Right-of-Use Asset 1.05M USD -44.3%
Other Assets, Noncurrent 1.69M USD -54.9%
Assets 319M USD +20.5%
Accounts Payable, Current 7.66M USD +83.4%
Accrued Liabilities, Current 27.3M USD +76.7%
Contract with Customer, Liability, Current 9.91M USD +3491%
Liabilities, Current 47M USD +118%
Contract with Customer, Liability, Noncurrent 321M USD +168%
Operating Lease, Liability, Noncurrent 133K USD -83.1%
Other Liabilities, Noncurrent 10.5M USD +39.3%
Liabilities 553M USD +124%
Retained Earnings (Accumulated Deficit) -1.1B USD -36.9%
Stockholders' Equity Attributable to Parent -234M USD -1429%
Liabilities and Equity 319M USD +20.5%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -69M USD -74%
Net Cash Provided by (Used in) Financing Activities 9.9M USD -29.6%
Net Cash Provided by (Used in) Investing Activities -40K USD +81.3%
Common Stock, Shares Authorized 400M shares 0%
Common Stock, Shares, Issued 58.6M shares +3.46%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -59.2M USD -129%
Interest Paid, Excluding Capitalized Interest, Operating Activities 3.74M USD +46.9%
Deferred Tax Assets, Valuation Allowance 176M USD +39.4%
Deferred Tax Assets, Gross 176M USD +39.2%
Operating Lease, Liability 853K USD -43.4%
Depreciation 500K USD -2.72%
Payments to Acquire Property, Plant, and Equipment 40K USD -81.3%
Lessee, Operating Lease, Liability, to be Paid 891K USD -45.5%
Property, Plant and Equipment, Gross 4.27M USD +47.3%
Operating Lease, Liability, Current 720K USD +0.42%
Lessee, Operating Lease, Liability, to be Paid, Year Two 513K USD -31.9%
Lessee, Operating Lease, Liability, to be Paid, Year One 513K USD -31.9%
Operating Lease, Weighted Average Discount Rate, Percent 0.08 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 38K USD -70.5%
Lessee, Operating Lease, Liability, to be Paid, Year Three 513K USD -3.03%
Deferred Tax Assets, Operating Loss Carryforwards 120M USD +39.8%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 40M shares 0%
Unrecognized Tax Benefits 3.01M USD +29.4%
Operating Lease, Payments 200K USD 0%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 214K USD +46.6%
Deferred Tax Assets, Net of Valuation Allowance 343K USD -28.7%
Share-based Payment Arrangement, Expense 42.4M USD +58.5%
Interest Expense 58.1M USD +54%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%